Alzheimer's drug slowed progression of the disease in Phase 3 trial

Experimental Alzheimer's drug shows benefits in phase 3 trial, company says Japanese drugmaker Eisai said cognitive decline slowed over 18 months in patients who received the drug, called lecanemab. Read More

Experimental Alzheimer’s drug shows benefits in phase 3 trial ... - TODAY

Experimental Alzheimer’s drug shows benefits in phase 3 trial, company says Japanese drugmaker Eisai said cognitive decline slowed over 18 months in patients who received the drug, called lecanemab. Read More

New Alzheimer's drug shows promise in phase 3 clinical trial

The new trial included almost 1,800 patients with early-stage Alzheimer's disease whose progress was tracked over 18 months. Investigators tracked cognition using what's known as the the CDR-SB ... Read More

Alzheimer’s Drug May Benefit Some Patients, New Data Shows

The hotly anticipated results of a clinical trial of an experimental Alzheimer’s drug suggest that the treatment slowed cognitive decline somewhat for people in the early stages of the disease ... Read More

Experimental drug could help prevent Alzheimer's in certain ... - Fox News

An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease. Here's what to know about the potential benefits and side effects. Read More

INmune Bio's Alzheimer's drug misses mid-stage goal, shares sink to record low

INmune Bio said on Monday its experimental Alzheimer's drug failed to improve cognitive functions in patients with early stages of the mind-robbing disease in a mid-stage study, sending its shares ... Read More

New study identifies a drug that could prevent Alzheimer's symptoms

A new study conducted by researchers from the Washington University School of Medicine identified an experimental drug that could be effective at preventing the onset of Alzheimer’s symptoms. Read More

Is This Experimental Drug A Promising Alzheimer's Treatment?

For the study, the researchers gave the study participants an experimental anti-amyloid drug. They found that 22 participants who had no cognitive problems at the study's start and who took the drug ... Read More

Drug to slow Alzheimer's well tolerated outside of clinical trial ...

The Food and Drug Administration's approval in 2023 of lecanemab -- a novel Alzheimer's therapy shown in clinical trials to modestly slow disease progression -- was met with enthusiasm by many in ... Read More

Novo's older obesity drug shows biological effect on Alzheimer's ...

Novo's older obesity drug shows biological effect on Alzheimer's patients in small trial By Julie Steenhuysen and Maggie Fick July 30, 2024 2:19 PM UTC Updated July 30, 2024 ... Read More

Experimental drug may slow dementia onset for patients with rare ... - MSN

An experimental treatment showed promising early results for reducing the risk of dementia related to Alzheimer’s for asymptomatic patients who are expected to develop the neurodegenerative ... Read More

Phase 1 Trial Shows Promise for Experimental Alzheimer's Drug

John Kuriyan, dean of basic sciences and University Distinguished Professor of Biochemistry and Chemistry at Vanderbilt University, not in volved in the study, said in a press release, "The successful ... Read More